(Q37337259)
Statements
Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes (English)
Berberis aristata
1 reference
Silybum marianum
1 reference
Francesco Di Pierro
Pietro Putignano
Nicola Villanova
Luca Montesi
Simona Moscatiello
1 November 2013
1 reference